Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

ShuttleNSE Citations (2)

Originally described in: A genetically encoded reporter for real-time imaging of cofilin-actin rods in living neurons.
Mi J, Shaw AE, Pak CW, Walsh KP, Minamide LS, Bernstein BW, Kuhn TB, Bamburg JR PLoS One. 2013 Dec 31;8(12):e83609. doi: 10.1371/journal.pone.0083609.
PubMed

Articles Citing ShuttleNSE

Articles
Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models. Chocron ES, Munkacsy E, Kim HS, Karpowicz P, Jiang N, Van Skike CE, DeRosa N, Banh AQ, Palavicini JP, Wityk P, Kalinowski L, Galvan V, Osmulski PA, Jankowska E, Gaczynska M, Pickering AM. Sci Adv. 2022 Jun 10;8(23):eabk2252. doi: 10.1126/sciadv.abk2252. Epub 2022 Jun 8. PubMed
Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome. Fadila S, Beucher B, Dopeso-Reyes IG, Mavashov A, Brusel M, Anderson K, Ismeurt C, Goldberg EM, Ricobaraza A, Hernandez-Alcoceba R, Kremer EJ, Rubinstein M. J Clin Invest. 2023 Jun 15;133(12):e159316. doi: 10.1172/JCI159316. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.